Omnipaque (Iohexol)

Iohexol, the active ingredient in Omnipaque, is a non‑ionic, low‑osmolality contrast medium presented as a solution for intravascular use. It enhances the visibility of vascular structures and organs during diagnostic imaging procedures in adults and children.

GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Omnipaque is a diagnostic imaging contrast agent used in radiographic procedures that require enhanced vascular and tissue delineation. - Computed Tomography (CT) scans: Improves image contrast for better detection of lesions, vascular anomalies, and organ pathology. - Angiography: Provides clear visualization of arterial and venous structures during catheter‑based studies. - Intravenous uro‑urography: Enhances the outline of the urinary tract for accurate assessment. - Myelography: Improves contrast of the spinal canal and nerve roots. - Contrast‑enhanced magnetic resonance imaging (MRI) (off‑label) : A         t

Common   g